Solon allocates medical fund for indigents | Inquirer News

Solon allocates medical fund for indigents

/ 09:46 AM December 15, 2011

CEBU 4th District Rep. Benhur Salimbangon recently signed an agreement with the Department of Social Welfare and Development in Central Visayas (DSWD-7) for the use P3 million from his Priority Assistance Development Fund to aid indigent individuals and families in his district.

The funds will cover expenses for medical treatment, medicine, laboratories, diagnostic procedures and other health requirements.

The congressman said this concern has been conceived to help alleviate the laboratory and diagnostic expenses incurred by his constituents, especially those who cannot afford to cope with high cost of medication.

Article continues after this advertisement

Salimbangon clarified that maximum assistance given to a client is P25,000.

FEATURED STORIES

He said those confined in private hospitals are not covered by the program unless they could show a certification from a government hospital stating that they could not be accommodated due to its full capacity.

Laboratory examinations in private hospitals and/or testing centers are also not allowed unless government hospitals and clinics will certify that such procedure is not available.

Article continues after this advertisement

Salimbangon said the challenges the DSWD is facing in helping the poor is no doubt a demonstration of the government’s move to make a difference for the poor constituents.

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: indigents

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.